New hope for Hard-to-Treat lung condition: drug targets inflammation
NCT ID NCT05679570
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 26 times
Summary
This study tests a drug called satralizumab in 20 adults with pulmonary arterial hypertension (PAH) who have high levels of the inflammatory marker IL-6 and haven't responded well to standard treatments. The main goal is to see if the drug improves blood flow in the lungs over 24 weeks. This is an early-phase trial focused on safety and effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chiba University Hospital
Chiba, 260-8677, Japan
-
Hokkaido University Hospital
Sapporo, 060-8648, Japan
-
International University of Health and Welfare Mita Hospital
Tokyo, 108-8329, Japan
-
Kagoshima University Hospital
Kagoshima, Kagoshima-ken, 890-8520, Japan
-
Kobe University Hospital
Kobe, 650-0017, Japan
-
Kurume University Hospital
Kurume, 830-0011, Japan
-
Kyorin University Hospital
Mitaka, 181-8611, Japan
-
Kyushu University Hospital
Fukuoka, 812-8582, Japan
-
Nagoya University Hospital
Nagoya, 466-8560, Japan
Conditions
Explore the condition pages connected to this study.